Virtual Reality vs Inperson Simulation: A Non-inferiority Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03863314 |
|
Recruitment Status :
Completed
First Posted : March 5, 2019
Last Update Posted : April 13, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Work-Related Condition | Device: Virtual Simulation Other: In-person Simulation | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 120 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Other |
| Official Title: | Virtual Reality vs Inperson Simulation: A Non-inferiority Study |
| Actual Study Start Date : | July 9, 2019 |
| Actual Primary Completion Date : | July 11, 2019 |
| Actual Study Completion Date : | November 15, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: In-Person Simulation
Participants will experience in-person simulations of different workplace scenarios such as medical error and workplace harassment
|
Other: In-person Simulation
In-person simulation of workplace-related scenarios with live actors |
|
Experimental: Virtual Simulation
Participants will experience virtual simulations of different workplace scenarios such as medical error and workplace harassment via Virtual Reality headset.
|
Device: Virtual Simulation
Virtual simulation of workplace-related scenarios of pre-recorded videos using the same actors |
- Respiratory sinus arrhythmia [ Time Frame: Throughout duration of simulation, approximately 15 minutes ]Biometric sensors will be placed in strategic locations in order to collect respiratory sinus arrhythmia throughout either in-person or virtual simulation
- Skin conductance levels [ Time Frame: Throughout duration of simulation, approximately 15 minutes ]Skin conductance levels as measured by electrodermal activity will be collected using biometric sensors throughout either in-person or virtual simulation
- Emotional levels [ Time Frame: Throughout duration of intervention, two minutes before and after the intervention ]Emotional affect will be self reported via validated scale before and after the intervention.
- VR Simulation Questionnaire [ Time Frame: Three months post study, approximately 5 minutes ]Participants will be given a questionnaire regarding their virtual or in-person simulation experience and the overall similarity to real-life on a scale from 1-5 (1=Completely Different and 5=Nearly Identical) Example Questions: "How true to real life were the emotions expressed during the scenario?" and "How true to real life was the the clinical environment?"
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Greater than 18 years of age
- Personnel working or volunteering at Lucile Packard Children's Hospital (LPCH) or Stanford Health Care (SHC) facilities
Exclusion Criteria:
- Patients who do not consent
- Are currently taking beta blockers or other chronotropic heart medication(s)
- Have a history of severe motion sickness
- Currently have nausea
- Currently experiencing seizures
- Are clinically unstable
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03863314
| United States, California | |
| Lucile Packard Children's Hospital Stanford | |
| Palo Alto, California, United States, 94304 | |
| Responsible Party: | Thomas Caruso, Clinical Associate Professor, Stanford University |
| ClinicalTrials.gov Identifier: | NCT03863314 |
| Other Study ID Numbers: |
48883 |
| First Posted: | March 5, 2019 Key Record Dates |
| Last Update Posted: | April 13, 2020 |
| Last Verified: | April 2020 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Virtual Reality Simulation Workplace |

